Tag: EW

  • The Best Companies of the Medical Industry – June 2015

    The Best Companies of the Medical Industry – June 2015

    While ModernGraham supports the bottom-up approach to investing, many investors do utilize the top-down method, whereby an industry is selected before the company itself. With that in mind, this article will take a brief look at the best companies of the medical industry, selecting the most promising investment opportunities within the industry, and giving a broad look into the industry as a whole.

  • The 6 Best Stocks For Value Investors This Week – 6/13/15

    The 6 Best Stocks For Value Investors This Week – 6/13/15

    We evaluated 16 different companies this week to determine whether they are suitable for Defensive Investors, those unwilling to do substantial research, or Enterprising Investors, those who are willing to do such research. Here’s a summary of the 6 best stocks from the week.

  • Edwards Lifesciences Corporation Analysis – June 2015 Update $EW

    Edwards Lifesciences Corporation Analysis – June 2015 Update $EW

    Edwards Lifesciences qualifies for the Enterprising Investor but not the more conservative Defensive Investor. The Defensive Investor is concerned with the lack of dividends, along with the high PEmg and PB ratios.

  • 18 Companies in the Spotlight This Week – 3/15/15

    18 Companies in the Spotlight This Week – 3/15/15

    We evaluated 18 different companies this week to determine whether they are suitable for Defensive Investors, those unwilling to do substantial research, or Enterprising Investors, those who are willing to do such research. We also put each company through the ModernGraham valuation model based on Benjamin Graham’s value investing formulas in order to determine an intrinsic value for each. Here’s a summary of the ModernGraham Valuations.

  • Edwards Lifesciences Corporation Quarterly Valuation – March 2015 $EW

    Edwards Lifesciences Corporation Quarterly Valuation – March 2015 $EW

    Edwards Lifesciences Corporation is suitable for the Enterprising Investor but not for the Defensive Investor. The Defensive Investor is concerned by the lack of dividend payments, and the high PEmg and PB ratios. The Enterprising Investor is only concerned by the lack of dividends.

  • 32 Companies in the Spotlight This Week – 12/6/14

    32 Companies in the Spotlight This Week – 12/6/14

    We evaluated 32 different companies this week to determine whether they are suitable for Defensive Investors, those unwilling to do substantial research, or Enterprising Investors, those who are willing to do such research. We also put each company through the ModernGraham valuation model based on Benjamin Graham’s value investing formulas in order to determine an intrinsic value for each. Here’s a summary of the ModernGraham Valuations.

  • Edwards Lifesciences Corporation Quarterly Valuation – November 2014 $EW

    Edwards Lifesciences Corporation Quarterly Valuation – November 2014 $EW

    Edwards Lifesciences Corp is suitable for the Enterprising Investor but not for the Defensive Investor. The Defensive Investor is concerned by the lack of dividends as well as the high PEmg and PB ratios, while the Enterprising Investor is only concerned by the lack of dividend payments.

  • 18 Companies to Research This Week – 8/30/2014

    18 Companies to Research This Week – 8/30/2014

    We evaluated 18 different companies this week to determine whether they are suitable for Defensive Investors, those unwilling to do substantial research, or Enterprising Investors, those who are willing to do such research. We also put each company through the ModernGraham valuation model based on Benjamin Graham’s value investing formulas in order to determine an intrinsic value for each. Here’s a summary of the ModernGraham Valuations.

  • Edwards Lifesceiences Corp Quarterly Valuation – August 2014 $EW

    Edwards Lifesceiences Corp Quarterly Valuation – August 2014 $EW

    Edwards Lifesciences does not qualify for the Defensive Investor but does satisfy the Enterprising Investor. The Defensive Investor has concerns with the lack of dividend payments and the high PEmg and PB ratios, while the Enterprising Investor’s only initial concern is the lack of dividend payments.